Show results for
Refine by
Applications
- Remote Patient Monitoring Solution for Remote Patient Monitoring
- Remote Patient Monitoring Solution for Revenue Cycle Management
- Remote Patient Monitoring Solution for EHR Integration
- Artesunate Injection for Malaria
- Artesunate Injection for Malaria Diagnosis of Malaria
- Artesunate Injection for Severe Malaria
- Microbiota for Restoration Therapy
- Microbiota Based Product for Physician-Sponsored Studies
- Medical cannabis solutions for regulatory pathway sector
- Medical cannabis solutions for mental health costs sector
- Brain Computer Interface Technology for Emagine Stroke Recovery
- Medical solutions for stomatology sector
- Medical solutions for phlebology sector
- Medical solutions for proctology sector
- Medical solutions for neurosurgery sector
Vaccine Producing Equipment & Supplies
85 equipment items found
Manufactured by:ARTES Biotechnology GmbH based inLangenfeld, GERMANY
ARTES offers a range of vaccine producing cell lines and processes for out-licensing and technology transfer. All listed cell lines are based on our safe and high yield yeast expression system Hansenula ...
Manufactured by:KM Biologics Co. Ltd. based inKumamoto, JAPAN
A hepatitis A vaccine produced by culturing hepatitis A virus on African green monkey kidney GL37 cells, followed by purification and inactivation. Aimmugen was developed in Japan. It is lyophilized and contains no adjuvants. Aimmugen can be administered subcutaneously or intramuscularly to people of all ages. ...
Manufactured by:KM Biologics Co. Ltd. based inKumamoto, JAPAN
An inactivated quadrivalent split (HA) seasonal influenza vaccine produced using embryonated chicken eggs. The vaccine contains 15 μg or more of HA proteins for each strain per adult dose. The strains used to make the vaccine are decided by the MHLW each ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
STING agonist-22 is a adjuvant by activating STING to induce the type I interferon (IFN-I) response and proinflammatory cytokine production. STING agonist-22 can be used as an adjuvant to boost the original protein vaccine, producing potent, broad, and long-term immune protection. STING agonist-22 can be used for SARS-CoV-2 variants and sarbecovirus diseases ...
Manufactured by:General Container Corp based inSomerset, NEW JERSEY (USA)
Due to their strength and reusability, General Container’s stainless steel drums deliver safety and ...
Manufactured by:C-CUBE based inHanoi, VIETNAM
This innovative modular vaccine production unit covers an area of 167 square meters, designed specifically for the rapid and efficient deployment of vaccine production capabilities worldwide. Its compact and versatile layout allows for quick assembly and operation in diverse geographical locations, meeting the increasing demand for vaccine ...
Manufactured by:Sanavita Pharmaceuticals GmbH based inHamburg, GERMANY
SANAVITA Re-Use Prevention Syringes are easy to handle. The safety function increases safety aspects by preventing reuse. At the end of the reconstitution or dilution process, the Type B function is manually activated and the syringe becomes unusable. SANAVITA Re-Use Prevention Syringes are already used for various vaccination campaigns. The product is sterilized by ethylene oxide (EO) ...
Manufactured by:The Native Antigen Company based inOxford, UNITED KINGDOM
Purified FHA from B. pertussis. This product is presented as at least 95% of the intact 220 kDa form, with 5% in the reported breakdown products of 140 kDa and 90 ...
Manufactured by:Sanavita Pharmaceuticals GmbH based inHamburg, GERMANY
SANAVITA Auto-disable syringes for fixed dose immunization are safe and easy to use. The evaluated technology activates the auto-disabling function the moment the dosage has been taken up. The syringe is rendered unusable immediately after injection of the vaccine. No manual activation is required. SANAVITA Auto-disable syringes are already used for various vaccination campaigns. The product is ...
Manufactured by:Leaf Expression Systems based inColney, UNITED KINGDOM
SupraVec is our proprietary expression technology, it allows for the rapid simultaneous production of multiple gene products in a controlled and coordinated manner within the tissues of plants. Using gene synthesis and modular vectors, new products, including antibodies, vaccines and complex natural products can be produced at speed and on a large scale. Our ...
Manufactured by:Steel Tech AS based inHovdebygda, NORWAY
The Steel Tech Duo Vaccination system is made of a number of standard Steel Tech products in order to allow both standard and DNA vaccination in one ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The SARS-CoV-2 Omicron variant became known to the general public recently (end of November 2021) and is characterized by many mutations in the Spike protein and other regions of the virus genome. It seems to spread even more rapidly than the Delta variant, and questions about the protection against this variant by presently used vaccines have been raised. This variant may have an increased ...
Manufactured by:Alfa Wassermann Separation Technologies (AWST) based inWest Caldwell, NEW JERSEY (USA)
The KII system is designed to expertly perform in FDA approved processes for the manufacture of viral vaccines, particulate proteins, gene therapies and ...
Manufactured by:Brevetti Angela S.r.l. based inArzignano, ITALY
The SYFPAC SVP TWIN machine is engineered to significantly enhance the production of small volume parenterals (SVP) by employing a unique double-decker mould design, achieving a 60% increase in productivity without additional floor space or clean room expansion. Catering to a volume range of 0.2ml to 20ml, it is suited for single-use containers and multi-dose vials. The machine maintains the same ...
Manufactured by:Bilthoven Biologicals based inBilthoven, NETHERLANDS
The DT-IPV combination vaccine (diphteria, tetanus and poliomyelitis) can be used as the first (primary) inoculation, or as a booster vaccination. The Dutch Vaccination Program (RVP), delivers booster vaccination via Bilthoven Biologicals to each 9 year old. DT-IPV vaccine is available in packaging for 1 or 10 ...
Manufactured by:BlueWillow Biologics based inAnn Arbor, MICHIGAN (USA)
Anthrax, though most commonly occurring in animals, can be extremely deadly to humans. Current vaccines can cause acute side effects and may provide only partial protection against some anthrax strains. Tests demonstrate that BlueWillow’s proprietary nanoemulsion (NE) adjuvant could deliver the next generation of anthrax ...
Manufactured by:Bilthoven Biologicals based inBilthoven, NETHERLANDS
Tetanus vaccine protects against infections with tetanus bacteria. Were you vaccinated with tetanus vaccine , DTaP-IPVor DTP-IPV longer than 10 years ago? In that case, you may need to be vaccinated again. A booster vaccination will protect you for another 10 ...
Manufactured by:Coolermed based inYunusemre, TURKEY
The double door M900ASI is the vaccine and medicine refrigerator that offers the most storage space with a net internal volume of 685 liters. Coolermed medical refrigerators are safely store cold chain products such as vaccines, medicines and medical products. The corrosion-resistant electrostatic powder coated outer body structure guarantees safe use for many ...
Manufactured by:Brevetti Angela S.r.l. based inArzignano, ITALY
The SYFPAC SVP system specializes in the aseptic primary packaging of small volume parenterals, ideal for vials and ampoules ranging from 0.2ml to 50ml. This machine supports the production of both single-use and multi-dose containers at a production speed of up to 16,000 units per hour, with potential upgrades to 25,000 units. Its design reduces clean room dimensions to 36 sqm and requires only ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Historically, we developed a vaccine candidate against MERS, a novel coronavirus first identified in 2012, as well as a vaccine candidate against SARS in 2005. In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major ...